InflaRx (IFRX) Liabilities and Shareholders Equity (2016 - 2026)

InflaRx has reported Liabilities and Shareholders Equity for 11 years, with the latest figure at $57.2 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity fell 37.45% year-over-year to $57.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $280.8 million (down 22.09% YoY) and the FY2025 annual result came in at $62.4 million, down 24.18% from the prior year.
• Liabilities and Shareholders Equity declined to $57.2 million in Q1 2026 per IFRX's latest filing, from $64.3 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $144.8 million in Q2 2023 and troughed at $57.2 million in Q1 2026.
• A 5-year average of $102.0 million and a median of $100.2 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2023 and 2024: Liabilities and Shareholders Equity grew 25.81% in 2023, then sank 37.91% in 2024.
• Over 5 years, Liabilities and Shareholders Equity stood at $104.5 million in 2022, then grew by 23.8% to $129.3 million in 2023, then plunged by 37.19% to $81.2 million in 2024, then retreated by 20.88% to $64.3 million in 2025, then decreased by 10.95% to $57.2 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $57.2 million, $64.3 million, and $76.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.